Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic

  • STATUS
    Recruiting
  • participants needed
    100
  • sponsor
    Stanford University
Send
Updated on 16 February 2024
See if I qualify
cognitive therapy
behavior therapy
insomnia
behavioral therapy
covid-19
sleep disturbances
cbt-i
cognitive behavioral therapy for insomnia
Cognitive Behavioral Therapy for Insomnia (CBT-I)

Summary

The purpose of this study is to investigate whether an empirically validated treatment for insomnia (CBT-I) administered early in the course of sleep disturbance can prevent insomnia disorder or lessen negative mental health outcomes in the wake of the COVID-19 crisis in adults.

Description

The COVID-19 Pandemic and the resulting mass home confinement enacted to mitigate disease spread has created an environment of stress and drastic disruption to daily life. Increases in stress, social isolation, loss of daily routine, decreased physical activity, and excess screen time that are likely to arise as a function of the pandemic and mitigation efforts are risk factors for developing insomnia. Left unchecked, this acute insomnia can become chronic, resulting in increased risk of negative mental health outcomes such as depression, anxiety, and suicidality. The current proposal aims to test whether a telehealth intervention for insomnia can be used to not only prevent the progression of acute to chronic insomnia, but also prevent the worsening of neuropsychiatric symptoms, suicidality, and quality of life in those most vulnerable to negative mental health outcomes.

These aims will be achieved through a randomized 2-arm controlled trial design. 100 eligible adults experiencing sleep disturbances and who also have a history of depression and are in the at-risk group for COVID-19 will be randomized to receive either a sleep intervention (Cognitive Behavioral Therapy for Insomnia, CBT-I; n=50) or a 7-month waitlist (n=50). CBT-I improves sleep patterns through a combination of sleep restriction, stimulus control, mindfulness training, cognitive therapy targeting dysfunctional beliefs about sleep, and sleep hygiene education. Neuropsychiatric symptoms, Quality of Life, suicidality, and sleep disruption will be assessed at baseline (Week 0) and at the end of the sleep intervention (or Week 7) through online surveys and clinical interviews. Neuropsychiatric symptoms (anxiety and depression) and sleep disturbance (Insomnia Severity Index, and sleep diaries) will be assayed at baseline and each week throughout treatment/waitlist to assess week-to-week changes following an increasing number of CBT-I sessions. Neuropsychiatric symptoms, quality of life, suicidality, and sleep will be assessed again at 3-months (Week 15), 7-months, and 13-months after baseline.

Details
Condition Insomnia, Insomnia, dyssomnia
Age 18years - 100years
Treatment Remote Cognitive Behavioral Therapy for Insomnia
Clinical Study IdentifierNCT04409743
SponsorStanford University
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Age 18 years or older
Access to the internet
Subjective complaint of sleep disturbance (ISI 10) that began after March 1, 2020 or the COVID-19 Pandemic (self-reported during DUKE Interview)
Lives in the United States

Exclusion Criteria

Presence of suicidal ideation representing high risk as measured by the Sheehan-Suicide Tracking Scale (S-STS)
Use of medication specifically prescribed for sleep disturbance and unwilling or unable to discontinue more than one week prior to baseline data collection
Current or lifetime history of bipolar disorder or psychosis
Current substance abuse or dependence
Not able to verbalize understanding of involvement in research and provide written, informed consent
Not fluent or literate in English
Unstable pharmacotherapy for other mental health disorders
Severe impediment to vision, hearing, and/or hand movement, likely to interfere with the ability to complete assessments, or are unable and/or unlikely to follow study protocols
Working rotating shift that overlaps with 2400h
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

cognitive therapy
behavior therapy
insomnia
behavioral therapy
covid-19
sleep disturbances
cbt-i
cognitive behavioral therapy for insomnia
Cognitive Behavioral Therapy for Insomnia (CBT-I)

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.